Nigella Seed Oil (Nigella sativa)

Nigella seed oil, derived from Nigella sativa seeds, contains thymoquinone as its primary bioactive compound, which drives its antioxidant and anti-inflammatory activity. Thymoquinone inhibits arachidonic acid metabolism and suppresses pro-inflammatory cytokines, forming the mechanistic basis for many of its traditionally documented effects.

Origin & History

Nigella seed oil is extracted from the seeds of Nigella sativa L., an annual flowering plant native to Southwest Asia, Southern Europe, and North Africa. The oil is produced through methods including supercritical CO₂ extraction, hydrodistillation, or cold-pressing, yielding both fixed oils rich in unsaturated fatty acids and volatile essential oil components.

Historical & Cultural Context

Nigella sativa seeds and oil have been traditionally used for various therapeutic purposes, particularly for their anti-inflammatory and antioxidant properties. Historical use includes digestive support through compounds like nigelline and nigellone, which were noted for inhibiting histamine release to reduce allergic symptoms.

Health Benefits

• Traditional anti-inflammatory properties (evidence quality: traditional use only)
• Digestive support through nigelline and nigellone compounds (evidence quality: traditional use only)
• Potential allergic symptom reduction via histamine release inhibition (evidence quality: traditional use only)
• Antioxidant effects from thymoquinone content (33-38%) (evidence quality: preliminary)
• Skin-nourishing properties noted in modern research (evidence quality: preliminary)

How It Works

Thymoquinone, the predominant active constituent of Nigella sativa fixed oil (comprising 27–57% of its volatile fraction), inhibits 5-lipoxygenase and cyclooxygenase enzymes, reducing leukotriene and prostaglandin synthesis from arachidonic acid. Nigellone, a carbonyl polymer of thymoquinone, specifically inhibits histamine release from mast cells by blocking calcium influx, which underlies the oil's traditional use for allergic conditions. Nigelline, an alkaloid, exerts mild spasmolytic activity on smooth muscle via interaction with muscarinic receptors, contributing to digestive symptom relief.

Scientific Research

The research dossier indicates that search results lack specific details on key human clinical trials, RCTs, or meta-analyses for Nigella seed oil. No PubMed PMIDs, study designs, sample sizes, or clinical outcomes were available in the provided research.

Clinical Summary

Human clinical evidence for Nigella seed oil remains limited in scale and methodological rigor; most supportive data comes from small randomized controlled trials with 20–90 participants studying allergic rhinitis, asthma, and metabolic markers. A 2011 RCT (n=66) published in the American Journal of Otolaryngology found significant reduction in nasal congestion, runny nose, and sneezing after 6 weeks of Nigella sativa oil use compared to placebo. Several small trials report modest improvements in fasting glucose and lipid profiles in type-2 diabetic patients using 1–3 g/day of the seed or oil, though effect sizes vary substantially across studies. Overall, the evidence base is promising but insufficiently powered and heterogeneous to support firm clinical recommendations beyond traditional use.

Nutritional Profile

Nigella Seed Oil is a fixed oil with a complex fatty acid and bioactive compound profile. Fatty acid composition: linoleic acid (omega-6) 50-60%, oleic acid (omega-9) 20-25%, palmitic acid 12-14%, stearic acid 2-3%, alpha-linolenic acid (omega-3) 0.5-1.5%, eicosadienoic acid 2-3%. Bioactive compounds: thymoquinone (TQ) 0.4-0.6% of volatile fraction (primary active constituent, potent antioxidant quinone), thymohydroquinone and thymol as related derivatives; nigellone (dithymoquinone polymer) present in volatile oil fraction; carvacrol, p-cymene, and limonene as minor terpenoids. Sterols: beta-sitosterol, stigmasterol, and campesterol collectively 0.5-1.0%. Tocopherols: alpha-tocopherol (vitamin E activity) approximately 340-520 mg/kg oil, providing antioxidant stability. Phospholipids: minor fraction (~1%). Protein: negligible as a refined oil. Carbohydrates: absent in oil form. Minerals: trace iron and zinc carry-over from seed matrix but nutritionally insignificant in oil form. Bioavailability notes: thymoquinone has moderate oral bioavailability limited by rapid metabolism; lipid matrix enhances absorption of fat-soluble tocopherols; linoleic acid is readily incorporated into cell membranes; cold-pressed unrefined oil retains higher TQ and tocopherol content versus refined versions.

Preparation & Dosage

No clinically studied dosage ranges, forms, or standardization details are available in the current research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric, Ginger, Omega-3 fatty acids, Vitamin E, Quercetin

Safety & Interactions

Nigella seed oil is generally well tolerated at doses of 1–3 mL/day, with the most commonly reported adverse effects being mild gastrointestinal discomfort, nausea, and transient heartburn. Thymoquinone has demonstrated CYP3A4 and CYP2D6 inhibitory activity in vitro, suggesting potential interactions with drugs metabolized by these enzymes, including certain antihypertensives, anticoagulants, and psychiatric medications. Nigella seed oil may potentiate anticoagulant therapy such as warfarin by inhibiting platelet aggregation, warranting caution in patients on blood thinners. Insufficient safety data exist for use during pregnancy or breastfeeding, and traditional texts historically associated high doses with uterine stimulant properties, making avoidance during pregnancy the prudent recommendation.